nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—Isopropamide—Benzphetamine—obesity	0.087	0.12	CrCrCtD
Mepenzolate—Benzatropine—Benzphetamine—obesity	0.0806	0.111	CrCrCtD
Mepenzolate—Levomethadyl Acetate—Benzphetamine—obesity	0.0728	0.1	CrCrCtD
Mepenzolate—Methadyl Acetate—Benzphetamine—obesity	0.0728	0.1	CrCrCtD
Mepenzolate—Diphenidol—Benzphetamine—obesity	0.0597	0.0823	CrCrCtD
Mepenzolate—Dextropropoxyphene—Benzphetamine—obesity	0.0597	0.0823	CrCrCtD
Mepenzolate—Diphenylpyraline—Benzphetamine—obesity	0.0569	0.0784	CrCrCtD
Mepenzolate—Fentanyl—Benzphetamine—obesity	0.0532	0.0733	CrCrCtD
Mepenzolate—Cyclizine—Benzphetamine—obesity	0.051	0.0703	CrCrCtD
Mepenzolate—Methadone—Benzphetamine—obesity	0.05	0.0689	CrCrCtD
Mepenzolate—Clofedanol—Benzphetamine—obesity	0.0432	0.0595	CrCrCtD
Mepenzolate—Benzyl Benzoate—Benzphetamine—obesity	0.0387	0.0534	CrCrCtD
Mepenzolate—Urinary hesitation—Phenylpropanolamine—obesity	0.00869	0.0527	CcSEcCtD
Mepenzolate—Sweating decreased—Topiramate—obesity	0.00483	0.0293	CcSEcCtD
Mepenzolate—Hypohidrosis—Topiramate—obesity	0.00483	0.0293	CcSEcCtD
Mepenzolate—Mydriasis—Diethylpropion—obesity	0.00372	0.0226	CcSEcCtD
Mepenzolate—Erectile dysfunction—Methamphetamine—obesity	0.00274	0.0167	CcSEcCtD
Mepenzolate—Urinary retention—Phenylpropanolamine—obesity	0.00246	0.0149	CcSEcCtD
Mepenzolate—Drowsiness—Phenylpropanolamine—obesity	0.00199	0.0121	CcSEcCtD
Mepenzolate—Erectile dysfunction—Phentermine—obesity	0.00197	0.012	CcSEcCtD
Mepenzolate—Urinary retention—Cimetidine—obesity	0.00195	0.0118	CcSEcCtD
Mepenzolate—Palpitations—Methamphetamine—obesity	0.00183	0.0111	CcSEcCtD
Mepenzolate—Palpitations—Benzphetamine—obesity	0.00177	0.0107	CcSEcCtD
Mepenzolate—Vision blurred—Phendimetrazine—obesity	0.00172	0.0104	CcSEcCtD
Mepenzolate—Erectile dysfunction—Diethylpropion—obesity	0.00171	0.0104	CcSEcCtD
Mepenzolate—Drowsiness—Diethylpropion—obesity	0.00166	0.0101	CcSEcCtD
Mepenzolate—Tachycardia—Methamphetamine—obesity	0.00165	0.01	CcSEcCtD
Mepenzolate—Mydriasis—Bupropion—obesity	0.00165	0.01	CcSEcCtD
Mepenzolate—Erectile dysfunction—Cimetidine—obesity	0.00163	0.0099	CcSEcCtD
Mepenzolate—Palpitations—Phendimetrazine—obesity	0.00161	0.00978	CcSEcCtD
Mepenzolate—Tachycardia—Benzphetamine—obesity	0.00159	0.00968	CcSEcCtD
Mepenzolate—Drowsiness—Cimetidine—obesity	0.00158	0.00959	CcSEcCtD
Mepenzolate—Insomnia—Methamphetamine—obesity	0.00153	0.0093	CcSEcCtD
Mepenzolate—Tension—Phenylpropanolamine—obesity	0.00153	0.00928	CcSEcCtD
Mepenzolate—Nervousness—Phenylpropanolamine—obesity	0.00151	0.00919	CcSEcCtD
Mepenzolate—Insomnia—Benzphetamine—obesity	0.00148	0.00897	CcSEcCtD
Mepenzolate—Vision blurred—Phenylpropanolamine—obesity	0.00147	0.00891	CcSEcCtD
Mepenzolate—Tension—Phentermine—obesity	0.00146	0.00888	CcSEcCtD
Mepenzolate—Accommodation disorder—Topiramate—obesity	0.00146	0.00885	CcSEcCtD
Mepenzolate—Tachycardia—Phendimetrazine—obesity	0.00145	0.00882	CcSEcCtD
Mepenzolate—Constipation—Methamphetamine—obesity	0.00145	0.00879	CcSEcCtD
Mepenzolate—Nervousness—Phentermine—obesity	0.00145	0.00879	CcSEcCtD
Mepenzolate—Insomnia—Phendimetrazine—obesity	0.00135	0.00817	CcSEcCtD
Mepenzolate—Urticaria—Methamphetamine—obesity	0.00135	0.00817	CcSEcCtD
Mepenzolate—Palpitations—Phentermine—obesity	0.00132	0.008	CcSEcCtD
Mepenzolate—Urticaria—Benzphetamine—obesity	0.0013	0.00788	CcSEcCtD
Mepenzolate—Confusional state—Phenylpropanolamine—obesity	0.00128	0.00778	CcSEcCtD
Mepenzolate—Constipation—Phendimetrazine—obesity	0.00127	0.00773	CcSEcCtD
Mepenzolate—Tension—Diethylpropion—obesity	0.00127	0.00773	CcSEcCtD
Mepenzolate—Nervousness—Diethylpropion—obesity	0.00126	0.00765	CcSEcCtD
Mepenzolate—Hypersensitivity—Methamphetamine—obesity	0.00125	0.00757	CcSEcCtD
Mepenzolate—Dry mouth—Phentermine—obesity	0.00124	0.00754	CcSEcCtD
Mepenzolate—Tachycardia—Phenylpropanolamine—obesity	0.00124	0.00753	CcSEcCtD
Mepenzolate—Vision blurred—Diethylpropion—obesity	0.00122	0.00742	CcSEcCtD
Mepenzolate—Hypersensitivity—Benzphetamine—obesity	0.0012	0.0073	CcSEcCtD
Mepenzolate—Tachycardia—Phentermine—obesity	0.00119	0.00721	CcSEcCtD
Mepenzolate—CHRM3—muscle of abdomen—obesity	0.00118	0.591	CbGeAlD
Mepenzolate—Insomnia—Phenylpropanolamine—obesity	0.00115	0.00698	CcSEcCtD
Mepenzolate—Palpitations—Diethylpropion—obesity	0.00115	0.00696	CcSEcCtD
Mepenzolate—Somnolence—Phenylpropanolamine—obesity	0.00113	0.00686	CcSEcCtD
Mepenzolate—Dizziness—Methamphetamine—obesity	0.00112	0.0068	CcSEcCtD
Mepenzolate—Insomnia—Phentermine—obesity	0.0011	0.00668	CcSEcCtD
Mepenzolate—Constipation—Phenylpropanolamine—obesity	0.00109	0.0066	CcSEcCtD
Mepenzolate—Dizziness—Benzphetamine—obesity	0.00108	0.00656	CcSEcCtD
Mepenzolate—Dry mouth—Diethylpropion—obesity	0.00108	0.00656	CcSEcCtD
Mepenzolate—Headache—Methamphetamine—obesity	0.00106	0.00644	CcSEcCtD
Mepenzolate—Mydriasis—Topiramate—obesity	0.00105	0.00638	CcSEcCtD
Mepenzolate—Feeling abnormal—Phenylpropanolamine—obesity	0.00105	0.00636	CcSEcCtD
Mepenzolate—Urinary retention—Sibutramine—obesity	0.00104	0.00632	CcSEcCtD
Mepenzolate—Constipation—Phentermine—obesity	0.00104	0.00632	CcSEcCtD
Mepenzolate—Ageusia—Topiramate—obesity	0.00103	0.00628	CcSEcCtD
Mepenzolate—Tachycardia—Diethylpropion—obesity	0.00103	0.00627	CcSEcCtD
Mepenzolate—Headache—Benzphetamine—obesity	0.00102	0.00621	CcSEcCtD
Mepenzolate—Confusional state—Cimetidine—obesity	0.00102	0.00616	CcSEcCtD
Mepenzolate—Anaphylactic shock—Cimetidine—obesity	0.00101	0.00611	CcSEcCtD
Mepenzolate—Abdominal distension—Orlistat—obesity	0.000985	0.00598	CcSEcCtD
Mepenzolate—Dizziness—Phendimetrazine—obesity	0.000985	0.00598	CcSEcCtD
Mepenzolate—Tachycardia—Cimetidine—obesity	0.000983	0.00597	CcSEcCtD
Mepenzolate—Nausea—Benzphetamine—obesity	0.00097	0.00589	CcSEcCtD
Mepenzolate—Urticaria—Phentermine—obesity	0.000967	0.00587	CcSEcCtD
Mepenzolate—Insomnia—Diethylpropion—obesity	0.000958	0.00581	CcSEcCtD
Mepenzolate—Abdominal distension—Sibutramine—obesity	0.000953	0.00578	CcSEcCtD
Mepenzolate—Somnolence—Diethylpropion—obesity	0.000941	0.00571	CcSEcCtD
Mepenzolate—Hypersensitivity—Phenylpropanolamine—obesity	0.000937	0.00569	CcSEcCtD
Mepenzolate—Headache—Phendimetrazine—obesity	0.000933	0.00566	CcSEcCtD
Mepenzolate—Urinary retention—Bupropion—obesity	0.000908	0.00551	CcSEcCtD
Mepenzolate—Constipation—Diethylpropion—obesity	0.000905	0.00549	CcSEcCtD
Mepenzolate—Somnolence—Cimetidine—obesity	0.000896	0.00544	CcSEcCtD
Mepenzolate—Nausea—Phendimetrazine—obesity	0.000884	0.00537	CcSEcCtD
Mepenzolate—Asthenia—Phentermine—obesity	0.000873	0.0053	CcSEcCtD
Mepenzolate—Feeling abnormal—Diethylpropion—obesity	0.000873	0.0053	CcSEcCtD
Mepenzolate—Erectile dysfunction—Sibutramine—obesity	0.000872	0.00529	CcSEcCtD
Mepenzolate—Constipation—Cimetidine—obesity	0.000862	0.00523	CcSEcCtD
Mepenzolate—Urticaria—Diethylpropion—obesity	0.000841	0.0051	CcSEcCtD
Mepenzolate—Dizziness—Phenylpropanolamine—obesity	0.000841	0.0051	CcSEcCtD
Mepenzolate—Abdominal distension—Bupropion—obesity	0.000831	0.00504	CcSEcCtD
Mepenzolate—Feeling abnormal—Cimetidine—obesity	0.00083	0.00504	CcSEcCtD
Mepenzolate—Vomiting—Phenylpropanolamine—obesity	0.000809	0.00491	CcSEcCtD
Mepenzolate—Dizziness—Phentermine—obesity	0.000805	0.00488	CcSEcCtD
Mepenzolate—Vomiting—Phentermine—obesity	0.000774	0.0047	CcSEcCtD
Mepenzolate—Headache—Phentermine—obesity	0.000763	0.00463	CcSEcCtD
Mepenzolate—Erectile dysfunction—Bupropion—obesity	0.00076	0.00461	CcSEcCtD
Mepenzolate—Nausea—Phenylpropanolamine—obesity	0.000756	0.00458	CcSEcCtD
Mepenzolate—Hypersensitivity—Cimetidine—obesity	0.000742	0.0045	CcSEcCtD
Mepenzolate—Nausea—Phentermine—obesity	0.000723	0.00439	CcSEcCtD
Mepenzolate—Asthenia—Cimetidine—obesity	0.000723	0.00439	CcSEcCtD
Mepenzolate—Dizziness—Diethylpropion—obesity	0.0007	0.00425	CcSEcCtD
Mepenzolate—Vomiting—Diethylpropion—obesity	0.000673	0.00409	CcSEcCtD
Mepenzolate—Dizziness—Cimetidine—obesity	0.000666	0.00404	CcSEcCtD
Mepenzolate—Headache—Diethylpropion—obesity	0.000663	0.00403	CcSEcCtD
Mepenzolate—Tension—Sibutramine—obesity	0.000647	0.00393	CcSEcCtD
Mepenzolate—Loperamide—POMC—obesity	0.000643	0.408	CrCbGaD
Mepenzolate—Vision blurred—Orlistat—obesity	0.000642	0.0039	CcSEcCtD
Mepenzolate—Nervousness—Sibutramine—obesity	0.000641	0.00389	CcSEcCtD
Mepenzolate—Vomiting—Cimetidine—obesity	0.000641	0.00389	CcSEcCtD
Mepenzolate—Headache—Cimetidine—obesity	0.000631	0.00383	CcSEcCtD
Mepenzolate—Nausea—Diethylpropion—obesity	0.000629	0.00382	CcSEcCtD
Mepenzolate—Vision blurred—Sibutramine—obesity	0.000622	0.00377	CcSEcCtD
Mepenzolate—Palpitations—Orlistat—obesity	0.000602	0.00365	CcSEcCtD
Mepenzolate—Nausea—Cimetidine—obesity	0.000598	0.00363	CcSEcCtD
Mepenzolate—Palpitations—Sibutramine—obesity	0.000583	0.00354	CcSEcCtD
Mepenzolate—Urinary retention—Topiramate—obesity	0.000578	0.00351	CcSEcCtD
Mepenzolate—Dry mouth—Orlistat—obesity	0.000567	0.00344	CcSEcCtD
Mepenzolate—Tension—Bupropion—obesity	0.000564	0.00342	CcSEcCtD
Mepenzolate—Nervousness—Bupropion—obesity	0.000558	0.00339	CcSEcCtD
Mepenzolate—Anaphylactic shock—Orlistat—obesity	0.000556	0.00338	CcSEcCtD
Mepenzolate—Aclidinium—BCHE—obesity	0.000555	0.352	CrCbGaD
Mepenzolate—Dry mouth—Sibutramine—obesity	0.000549	0.00333	CcSEcCtD
Mepenzolate—Confusional state—Sibutramine—obesity	0.000543	0.00329	CcSEcCtD
Mepenzolate—Vision blurred—Bupropion—obesity	0.000542	0.00329	CcSEcCtD
Mepenzolate—Anaphylactic shock—Sibutramine—obesity	0.000538	0.00327	CcSEcCtD
Mepenzolate—Abdominal distension—Topiramate—obesity	0.000529	0.00321	CcSEcCtD
Mepenzolate—Tachycardia—Sibutramine—obesity	0.000525	0.00319	CcSEcCtD
Mepenzolate—Palpitations—Bupropion—obesity	0.000508	0.00308	CcSEcCtD
Mepenzolate—Insomnia—Orlistat—obesity	0.000503	0.00305	CcSEcCtD
Mepenzolate—Insomnia—Sibutramine—obesity	0.000487	0.00295	CcSEcCtD
Mepenzolate—Erectile dysfunction—Topiramate—obesity	0.000484	0.00294	CcSEcCtD
Mepenzolate—Dry mouth—Bupropion—obesity	0.000479	0.00291	CcSEcCtD
Mepenzolate—Somnolence—Sibutramine—obesity	0.000479	0.0029	CcSEcCtD
Mepenzolate—Confusional state—Bupropion—obesity	0.000473	0.00287	CcSEcCtD
Mepenzolate—Anaphylactic shock—Bupropion—obesity	0.000469	0.00285	CcSEcCtD
Mepenzolate—Constipation—Sibutramine—obesity	0.00046	0.00279	CcSEcCtD
Mepenzolate—Feeling abnormal—Orlistat—obesity	0.000458	0.00278	CcSEcCtD
Mepenzolate—Tachycardia—Bupropion—obesity	0.000458	0.00278	CcSEcCtD
Mepenzolate—Feeling abnormal—Sibutramine—obesity	0.000444	0.00269	CcSEcCtD
Mepenzolate—Urticaria—Orlistat—obesity	0.000442	0.00268	CcSEcCtD
Mepenzolate—Urticaria—Sibutramine—obesity	0.000428	0.0026	CcSEcCtD
Mepenzolate—Insomnia—Bupropion—obesity	0.000424	0.00258	CcSEcCtD
Mepenzolate—Somnolence—Bupropion—obesity	0.000417	0.00253	CcSEcCtD
Mepenzolate—Hypersensitivity—Orlistat—obesity	0.00041	0.00249	CcSEcCtD
Mepenzolate—Constipation—Bupropion—obesity	0.000401	0.00244	CcSEcCtD
Mepenzolate—Asthenia—Orlistat—obesity	0.000399	0.00242	CcSEcCtD
Mepenzolate—Hypersensitivity—Sibutramine—obesity	0.000397	0.00241	CcSEcCtD
Mepenzolate—Feeling abnormal—Bupropion—obesity	0.000387	0.00235	CcSEcCtD
Mepenzolate—Asthenia—Sibutramine—obesity	0.000386	0.00234	CcSEcCtD
Mepenzolate—Urticaria—Bupropion—obesity	0.000373	0.00226	CcSEcCtD
Mepenzolate—Dizziness—Orlistat—obesity	0.000368	0.00223	CcSEcCtD
Mepenzolate—Tension—Topiramate—obesity	0.000359	0.00218	CcSEcCtD
Mepenzolate—Dizziness—Sibutramine—obesity	0.000356	0.00216	CcSEcCtD
Mepenzolate—Nervousness—Topiramate—obesity	0.000356	0.00216	CcSEcCtD
Mepenzolate—Vomiting—Orlistat—obesity	0.000354	0.00215	CcSEcCtD
Mepenzolate—Headache—Orlistat—obesity	0.000348	0.00211	CcSEcCtD
Mepenzolate—Hypersensitivity—Bupropion—obesity	0.000346	0.0021	CcSEcCtD
Mepenzolate—Vision blurred—Topiramate—obesity	0.000345	0.0021	CcSEcCtD
Mepenzolate—Vomiting—Sibutramine—obesity	0.000342	0.00208	CcSEcCtD
Mepenzolate—Headache—Sibutramine—obesity	0.000337	0.00205	CcSEcCtD
Mepenzolate—Asthenia—Bupropion—obesity	0.000337	0.00204	CcSEcCtD
Mepenzolate—Nausea—Orlistat—obesity	0.00033	0.002	CcSEcCtD
Mepenzolate—Palpitations—Topiramate—obesity	0.000324	0.00196	CcSEcCtD
Mepenzolate—Nausea—Sibutramine—obesity	0.00032	0.00194	CcSEcCtD
Mepenzolate—Dizziness—Bupropion—obesity	0.00031	0.00188	CcSEcCtD
Mepenzolate—Dry mouth—Topiramate—obesity	0.000305	0.00185	CcSEcCtD
Mepenzolate—Confusional state—Topiramate—obesity	0.000301	0.00183	CcSEcCtD
Mepenzolate—Vomiting—Bupropion—obesity	0.000298	0.00181	CcSEcCtD
Mepenzolate—Headache—Bupropion—obesity	0.000294	0.00178	CcSEcCtD
Mepenzolate—Tachycardia—Topiramate—obesity	0.000292	0.00177	CcSEcCtD
Mepenzolate—Nausea—Bupropion—obesity	0.000279	0.00169	CcSEcCtD
Mepenzolate—Insomnia—Topiramate—obesity	0.00027	0.00164	CcSEcCtD
Mepenzolate—Somnolence—Topiramate—obesity	0.000266	0.00161	CcSEcCtD
Mepenzolate—Constipation—Topiramate—obesity	0.000256	0.00155	CcSEcCtD
Mepenzolate—Feeling abnormal—Topiramate—obesity	0.000246	0.0015	CcSEcCtD
Mepenzolate—Levomethadyl Acetate—CYP19A1—obesity	0.000238	0.151	CrCbGaD
Mepenzolate—Urticaria—Topiramate—obesity	0.000238	0.00144	CcSEcCtD
Mepenzolate—Hypersensitivity—Topiramate—obesity	0.00022	0.00134	CcSEcCtD
Mepenzolate—Asthenia—Topiramate—obesity	0.000215	0.0013	CcSEcCtD
Mepenzolate—Dizziness—Topiramate—obesity	0.000198	0.0012	CcSEcCtD
Mepenzolate—Vomiting—Topiramate—obesity	0.00019	0.00115	CcSEcCtD
Mepenzolate—Headache—Topiramate—obesity	0.000187	0.00114	CcSEcCtD
Mepenzolate—Nausea—Topiramate—obesity	0.000178	0.00108	CcSEcCtD
Mepenzolate—CHRM2—cardiovascular system—obesity	0.000159	0.0791	CbGeAlD
Mepenzolate—CHRM1—cardiovascular system—obesity	0.000144	0.072	CbGeAlD
Mepenzolate—Methadone—CYP19A1—obesity	0.00014	0.0886	CrCbGaD
Mepenzolate—CHRM3—adipose tissue—obesity	0.000114	0.0568	CbGeAlD
Mepenzolate—CHRM2—endocrine gland—obesity	0.000109	0.0543	CbGeAlD
Mepenzolate—CHRM3—digestive system—obesity	0.000107	0.0535	CbGeAlD
Mepenzolate—CHRM1—endocrine gland—obesity	9.9e-05	0.0494	CbGeAlD
Mepenzolate—CHRM3—endocrine gland—obesity	8.86e-05	0.0442	CbGeAlD
Mepenzolate—CHRM3—Signaling Pathways—CNR1—obesity	1.41e-05	0.000133	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GNB3—obesity	1.41e-05	0.000133	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PPARGC1A—obesity	1.41e-05	0.000133	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—HMOX1—obesity	1.4e-05	0.000132	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CNR1—obesity	1.4e-05	0.000132	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TCF7L2—obesity	1.39e-05	0.000131	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TCF7L2—obesity	1.39e-05	0.000131	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—AKT2—obesity	1.39e-05	0.000131	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—DRD2—obesity	1.38e-05	0.000131	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—AKT2—obesity	1.38e-05	0.00013	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—DRD2—obesity	1.38e-05	0.00013	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PIK3CG—obesity	1.38e-05	0.00013	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TCF7L2—obesity	1.37e-05	0.00013	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PIK3CG—obesity	1.37e-05	0.000129	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GNAS—obesity	1.37e-05	0.000129	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PTPN1—obesity	1.37e-05	0.000129	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GCG—obesity	1.37e-05	0.000129	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—AKT2—obesity	1.37e-05	0.000129	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—DRD2—obesity	1.36e-05	0.000129	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PTPN1—obesity	1.36e-05	0.000129	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GCG—obesity	1.36e-05	0.000129	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PIK3CG—obesity	1.36e-05	0.000128	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PTPN1—obesity	1.35e-05	0.000128	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GCG—obesity	1.35e-05	0.000128	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APOB—obesity	1.34e-05	0.000127	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PIK3CD—obesity	1.33e-05	0.000126	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PIK3CD—obesity	1.33e-05	0.000125	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PIK3CD—obesity	1.31e-05	0.000124	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—POMC—obesity	1.31e-05	0.000124	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PRL—obesity	1.31e-05	0.000123	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—POMC—obesity	1.3e-05	0.000123	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PRL—obesity	1.3e-05	0.000123	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—POMC—obesity	1.29e-05	0.000122	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PRL—obesity	1.29e-05	0.000122	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—STK11—obesity	1.29e-05	0.000122	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—STK11—obesity	1.28e-05	0.000121	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CCL2—obesity	1.28e-05	0.000121	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—LPL—obesity	1.28e-05	0.000121	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CCL2—obesity	1.28e-05	0.000121	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PLG—obesity	1.27e-05	0.00012	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—RHOA—obesity	1.27e-05	0.00012	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—STK11—obesity	1.27e-05	0.00012	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PLG—obesity	1.27e-05	0.00012	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—RHOA—obesity	1.27e-05	0.00012	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CCL2—obesity	1.26e-05	0.000119	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—AKT2—obesity	1.26e-05	0.000119	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PIK3R1—obesity	1.26e-05	0.000119	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PLG—obesity	1.26e-05	0.000119	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—AKT2—obesity	1.25e-05	0.000118	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—RHOA—obesity	1.25e-05	0.000118	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PIK3R1—obesity	1.25e-05	0.000118	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GPX1—obesity	1.25e-05	0.000118	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—AKT2—obesity	1.24e-05	0.000117	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—FOXO3—obesity	1.24e-05	0.000117	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PIK3R1—obesity	1.24e-05	0.000117	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ADRB2—obesity	1.24e-05	0.000117	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—FOXO3—obesity	1.24e-05	0.000117	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ADRB2—obesity	1.23e-05	0.000117	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—FOXO3—obesity	1.23e-05	0.000116	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ADRB2—obesity	1.22e-05	0.000115	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SOCS1—obesity	1.22e-05	0.000115	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CD36—obesity	1.22e-05	0.000115	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SOCS1—obesity	1.22e-05	0.000115	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PIK3CD—obesity	1.21e-05	0.000114	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PIK3CD—obesity	1.21e-05	0.000114	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SOCS3—obesity	1.2e-05	0.000114	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SOCS1—obesity	1.2e-05	0.000114	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SOCS3—obesity	1.2e-05	0.000113	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PIK3CD—obesity	1.19e-05	0.000113	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SOCS3—obesity	1.19e-05	0.000112	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GNB3—obesity	1.18e-05	0.000111	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GNB3—obesity	1.18e-05	0.000111	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GNB3—obesity	1.16e-05	0.00011	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—TYK2—obesity	1.16e-05	0.00011	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PIK3CB—obesity	1.16e-05	0.00011	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—TYK2—obesity	1.16e-05	0.000109	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IGF2—obesity	1.16e-05	0.000109	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PIK3CB—obesity	1.16e-05	0.000109	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IGF2—obesity	1.15e-05	0.000109	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—RHOA—obesity	1.15e-05	0.000109	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—MTHFR—obesity	1.15e-05	0.000109	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—RHOA—obesity	1.15e-05	0.000109	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GNAS—obesity	1.15e-05	0.000108	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—TYK2—obesity	1.15e-05	0.000108	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PIK3CB—obesity	1.15e-05	0.000108	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GNAS—obesity	1.14e-05	0.000108	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IGF2—obesity	1.14e-05	0.000108	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PIK3R1—obesity	1.14e-05	0.000108	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—RHOA—obesity	1.14e-05	0.000108	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PIK3R1—obesity	1.14e-05	0.000107	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GNAS—obesity	1.13e-05	0.000107	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PPARA—obesity	1.13e-05	0.000107	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PIK3R1—obesity	1.13e-05	0.000106	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APOB—obesity	1.12e-05	0.000106	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APOB—obesity	1.12e-05	0.000106	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APOB—obesity	1.11e-05	0.000105	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCL5—obesity	1.1e-05	0.000104	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—AGT—obesity	1.1e-05	0.000103	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCL5—obesity	1.09e-05	0.000103	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCL5—obesity	1.08e-05	0.000102	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—LPL—obesity	1.07e-05	0.000101	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APOE—obesity	1.07e-05	0.000101	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—LPL—obesity	1.07e-05	0.000101	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—FOXO1—obesity	1.07e-05	0.000101	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—RPS6KB1—obesity	1.06e-05	0.000101	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CAV1—obesity	1.06e-05	0.0001	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—FOXO1—obesity	1.06e-05	0.0001	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—RPS6KB1—obesity	1.06e-05	0.0001	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APOA1—obesity	1.06e-05	0.0001	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—LPL—obesity	1.06e-05	0.0001	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PIK3CB—obesity	1.05e-05	9.95e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—FOXO1—obesity	1.05e-05	9.94e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—RPS6KB1—obesity	1.05e-05	9.92e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PIK3CB—obesity	1.05e-05	9.92e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PIK3CB—obesity	1.04e-05	9.82e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PRKCD—obesity	9.89e-06	9.34e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PRKCD—obesity	9.86e-06	9.31e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PRKCD—obesity	9.77e-06	9.22e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PIK3CG—obesity	9.69e-06	9.15e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HTR2A—obesity	9.68e-06	9.14e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—C3—obesity	9.67e-06	9.13e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HTR2A—obesity	9.65e-06	9.11e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—C3—obesity	9.64e-06	9.1e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HTR2A—obesity	9.56e-06	9.03e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—C3—obesity	9.55e-06	9.01e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PPARG—obesity	9.35e-06	8.83e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—POMC—obesity	9.22e-06	8.71e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IRS2—obesity	9.2e-06	8.69e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AGT—obesity	9.19e-06	8.68e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IRS2—obesity	9.17e-06	8.66e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—INS—obesity	9.17e-06	8.66e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AGT—obesity	9.16e-06	8.65e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IRS2—obesity	9.08e-06	8.57e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AGT—obesity	9.07e-06	8.56e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—LEP—obesity	9e-06	8.5e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APOE—obesity	9e-06	8.5e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APOE—obesity	8.97e-06	8.47e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—LEP—obesity	8.97e-06	8.47e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CAV1—obesity	8.92e-06	8.42e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APOA1—obesity	8.9e-06	8.4e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CAV1—obesity	8.89e-06	8.4e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—LEP—obesity	8.89e-06	8.39e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APOE—obesity	8.89e-06	8.39e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APOA1—obesity	8.87e-06	8.38e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CAV1—obesity	8.8e-06	8.31e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APOA1—obesity	8.78e-06	8.3e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ESR1—obesity	8.59e-06	8.12e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ESR1—obesity	8.57e-06	8.09e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PIK3CD—obesity	8.51e-06	8.04e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—F2—obesity	8.49e-06	8.02e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PRKCB—obesity	8.49e-06	8.02e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ESR1—obesity	8.48e-06	8.01e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—F2—obesity	8.46e-06	7.99e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PRKCB—obesity	8.46e-06	7.99e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ALB—obesity	8.4e-06	7.94e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—BAD—obesity	8.39e-06	7.92e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—F2—obesity	8.38e-06	7.91e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PRKCB—obesity	8.38e-06	7.91e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—BAD—obesity	8.36e-06	7.9e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—BAD—obesity	8.28e-06	7.82e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PIK3CG—obesity	8.12e-06	7.67e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PIK3CG—obesity	8.1e-06	7.65e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PIK3R1—obesity	8.04e-06	7.59e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—NOS3—obesity	8.04e-06	7.59e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IRS1—obesity	8.03e-06	7.58e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PIK3CG—obesity	8.02e-06	7.57e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IRS1—obesity	8e-06	7.56e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IRS1—obesity	7.93e-06	7.49e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—POMC—obesity	7.73e-06	7.3e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—POMC—obesity	7.71e-06	7.28e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—INS—obesity	7.69e-06	7.26e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—INS—obesity	7.67e-06	7.24e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—POMC—obesity	7.63e-06	7.21e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—INS—obesity	7.59e-06	7.17e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCL2—obesity	7.57e-06	7.15e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCL2—obesity	7.54e-06	7.12e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCL2—obesity	7.47e-06	7.05e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IGF1—obesity	7.44e-06	7.02e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AKT2—obesity	7.43e-06	7.02e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PIK3CB—obesity	7.42e-06	7.01e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IGF1—obesity	7.41e-06	7e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AKT2—obesity	7.41e-06	7e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PTGS2—obesity	7.35e-06	6.94e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IGF1—obesity	7.34e-06	6.93e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AKT2—obesity	7.34e-06	6.93e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PIK3CD—obesity	7.14e-06	6.74e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PIK3CD—obesity	7.12e-06	6.72e-05	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PIK3CA—obesity	7.07e-06	6.68e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SERPINE1—obesity	7.06e-06	6.67e-05	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PIK3CA—obesity	7.05e-06	6.66e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PIK3CD—obesity	7.05e-06	6.66e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SERPINE1—obesity	7.04e-06	6.65e-05	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PIK3CA—obesity	6.98e-06	6.59e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SERPINE1—obesity	6.97e-06	6.58e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TYK2—obesity	6.87e-06	6.49e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TYK2—obesity	6.85e-06	6.47e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—RHOA—obesity	6.81e-06	6.43e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—RHOA—obesity	6.79e-06	6.41e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TYK2—obesity	6.78e-06	6.4e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NOS3—obesity	6.74e-06	6.37e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PIK3R1—obesity	6.74e-06	6.37e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—RHOA—obesity	6.73e-06	6.35e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NOS3—obesity	6.72e-06	6.35e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PIK3R1—obesity	6.72e-06	6.35e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NOS3—obesity	6.66e-06	6.29e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PIK3R1—obesity	6.66e-06	6.29e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PIK3CA—obesity	6.42e-06	6.07e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PIK3CA—obesity	6.4e-06	6.05e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PIK3CA—obesity	6.34e-06	5.99e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MTOR—obesity	6.23e-06	5.88e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PIK3CB—obesity	6.23e-06	5.88e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MTOR—obesity	6.21e-06	5.86e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PIK3CB—obesity	6.21e-06	5.86e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MTOR—obesity	6.15e-06	5.8e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PIK3CB—obesity	6.15e-06	5.8e-05	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—AKT1—obesity	5.78e-06	5.46e-05	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—AKT1—obesity	5.76e-06	5.44e-05	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—AKT1—obesity	5.7e-06	5.39e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—IL6—obesity	5.69e-06	5.37e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—IL6—obesity	5.67e-06	5.35e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—IL6—obesity	5.62e-06	5.3e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MMP9—obesity	5.41e-06	5.11e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MMP9—obesity	5.39e-06	5.09e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MMP9—obesity	5.34e-06	5.04e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MAPK8—obesity	5.26e-06	4.97e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—AKT1—obesity	5.25e-06	4.96e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MAPK8—obesity	5.25e-06	4.95e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—AKT1—obesity	5.23e-06	4.94e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MAPK8—obesity	5.19e-06	4.91e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—AKT1—obesity	5.18e-06	4.89e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—STAT3—obesity	4.81e-06	4.54e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—STAT3—obesity	4.8e-06	4.53e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—STAT3—obesity	4.75e-06	4.48e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PIK3CA—obesity	4.52e-06	4.27e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MYC—obesity	4.47e-06	4.22e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TGFB1—obesity	4.46e-06	4.21e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MYC—obesity	4.46e-06	4.21e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TGFB1—obesity	4.45e-06	4.2e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MYC—obesity	4.41e-06	4.17e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TGFB1—obesity	4.4e-06	4.16e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PIK3CA—obesity	3.79e-06	3.58e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PIK3CA—obesity	3.78e-06	3.57e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PIK3CA—obesity	3.75e-06	3.54e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—AKT1—obesity	3.7e-06	3.49e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IL6—obesity	3.36e-06	3.17e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IL6—obesity	3.35e-06	3.16e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IL6—obesity	3.32e-06	3.13e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AKT1—obesity	3.1e-06	2.93e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AKT1—obesity	3.09e-06	2.92e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AKT1—obesity	3.06e-06	2.89e-05	CbGpPWpGaD
